No description available.

No description available.

Thesis (M.S.)--Indiana University, 2008. / Title from screen (viewed on January 26, 2010). Department of Cellular & Integrative Physiology, Indiana University-Purdue University Indianapolis (IUPUI). Advisor(s): Navin Bansal, Andriy M. Babsky, Stephen A. Kempson, David P. Basile. Includes vitae. Includes bibliographical references (leaves 33-36).

Indiana University-Purdue University Indianapolis (IUPUI) / In present study, single quantum (SQ) and triple quantum filtered (TQF) 23Na magnetic resonance imaging (MRI) was used to monitor the severity and progression of CCl4 induced acute and chronic liver damage in rat model. SQ 23Na MRI was proposed to measure the 23Na signal intensity (SI) of total tissue sodium ions, and TQF 23Na MRI was proposed to measure the SI of intracellular sodium ions. In addition, shift reagent aided 23Na and 31P magnetic resonance spectroscopy (MRS) was used to measure in vivo intracellular sodium concentration ([Na+i]), total tissue sodium concentration ([Na+t]) and relative extracellular space (rECS) of liver in the same model. In acute high dose CCl4 intoxication, 24 hours after single dose of CCl4 in 5ml per kg body weight of mixture of CCl4 and oil in 1:1 ratio, SQ 23Na SI increased by 83% and TQF 23Na SI increased by 174% compared to the baseline level. According to SR-aided 23Na and 31P MRS, [Na+i] increased by 188% and [Na+t] increased by 43%. In addition, there was significant decrease in cellular energetic level, represented by ATP/Pi ratio. Histology examination showed pronounced inflammatory response in centrilobular regions, with neutrophiles infiltration, fatty accumulation and swollen hepatocytes. In chronic 8-week experiment, chronic damage was induced by biweekly administration of CCl4 in a dosage of 0.5 ml per kg body weight. From week 1 to week 6, SQ 23Na SI remained relatively constant, and then increased by 15% from week 6 to week 8. TQF 23Na SI progressively increased from week 1 to week 8, totally by 56%. Both SQ and TQF 23Na SI showed significant difference between treated group and control at every week. SR-aided 23Na and 31P MRS experiment showed that, at the end of 8-week CCl4 intoxication, both [Na+t] and rECS were higher than control, by 49% and 47% respectively; however, there was no significant difference for [Na+i] between two groups. Histology examination showed excessive deposition of extracellular matrix. In conclusion, SQ and TQF 23Na MRI appears valuable in the functional assessment of liver in noninvasive approach, and could be a promising diagnostic modality for liver diseases in clinical area.

京都大学 / 新制・課程博士 / 博士(農学) / 甲第24109号 / 農博第2514号 / 新制||農||1093(附属図書館) / 学位論文||R4||N5400(農学部図書室) / 京都大学大学院農学研究科応用生物科学専攻 / (主査)教授 佐藤 健司, 教授 菅原 達也, 准教授 木下 政人 / 学位規則第4条第1項該当 / Doctor of Agricultural Science / Kyoto University / DGAM

Master thesis summarizes latest knowledge in the field of special nutrition for patients with liver condition. Theoretical chapters describe liver physiology and etiology of selected liver diseases e.g. hepatitis, cirrhosis, chemical-driven liver damage. Given the fact the main cause of chronic liver disease is globally considered alcohol, a special chapter is dedicated to this topic which describes pathogenesis of alcoholic liver disease, the effect of chronic alcohol consumption on hepatocytes and other non-parenchymal liver cells. The thesis provides a comprehensive view on the issue of malnutrition and nutrition recommendations in specific liver disease. Practical part of the thesis involved complex questioning of healthcare providers - doctors and nurses - from selected hospital and presents overview of healthcare providers knowledge regarding latest nutrition recommendations in specific liver disease. Key words: liver damage, malnutrition, alcohol, nutrition, diet, cirrhosis, liver physiology

Submitted by Izabel Franco (izabel-franco@ufscar.br) on 2016-09-15T14:31:09Z No. of bitstreams: 1 TeseMGP.pdf: 6082207 bytes, checksum: 573b75094c040d929b1f8f03f927018e (MD5) / Approved for entry into archive by Marina Freitas (marinapf@ufscar.br) on 2016-09-16T19:25:25Z (GMT) No. of bitstreams: 1 TeseMGP.pdf: 6082207 bytes, checksum: 573b75094c040d929b1f8f03f927018e (MD5) / Approved for entry into archive by Marina Freitas (marinapf@ufscar.br) on 2016-09-16T19:25:35Z (GMT) No. of bitstreams: 1 TeseMGP.pdf: 6082207 bytes, checksum: 573b75094c040d929b1f8f03f927018e (MD5) / Made available in DSpace on 2016-09-16T19:25:46Z (GMT). No. of bitstreams: 1 TeseMGP.pdf: 6082207 bytes, checksum: 573b75094c040d929b1f8f03f927018e (MD5) Previous issue date: 2015-05-29 / Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) / Eutrophication of the aquatic environment favors cyanobacteria blooms and affects the biota due to organoleptic water changing and the release of toxins. The objective of this study was to evaluate the effect of microcystin contained in the crude extract of the cyanobacteria Radiocystis fernandoi (R28 strain) in the fish Hoplias malabaricus assessing the degree of structural and functional impairment of the liver, the accumulation potential in muscle and risk to human health. Traíras were injected intraperitoneally with 100 μg MC-LReq kg-1 following two experimental protocols: (i) acute exposure with the application of a single dose of the crude extract and evaluation after 12 and 96 hours and (II) chronic exposure in which a dose was injected every 72 hours during 30 days. Genotoxic, biochemical, physiological and morphological biomarkers were used to evaluate the action of toxins, structural and ultrastructural damage in the liver, the detoxification mechanisms and changes in energy metabolism. The R28 strain produced mainly the MC-RR and MC-YR showing hepatotoxic potential. In the liver there was accumulation of MC-YR after acute and chronic exposure and MC-RR and MC-RR only after chronic exposure. There was not MC accumulation in muscle. The accumulation of the variants (MC-RR and MC-YR) depends on the concentration and the body's defense system for depuration and biomagnification. Acute and chronic exposure caused inhibition of the serine protein phosphatase / threonine type of PP2A activity, increased alanine aminotransferase and aspartate activity and direct bilirubin in plasma indicating liver damage. Macroscopically occurred changes in the color, texture and liver mass; microscopically the morphology of hepatocytes and intracellular organelles were altered and there were dilated sinusoids and hyperemia. After 30 days, the frequency of changes increase, and fibrous tissue disrupted the architecture of hepatic tissue. Changes in intermediary metabolism as glucose, liver glycogen, pyruvate and lactate showed increased energy demand and physiological stress. Moreover, there was activation of phase I of the biotransformation system and alterations in cellular antioxidant systems. Morphological signs of recovery in the liver were observed after 96 hours (single dose) to MC, but not after 30 days and no signs of cell regeneration. DNA damage were observed as well. The biochemical changes and liver structure showed functional impairment of the liver. In conclusion, the microcystin present in the crude extract of cyanobacteria R. fernandoi (R28 strain) combined with other substances in the extract may compromise the health and survival of the animal. / A eutrofização do ambiente aquático favorece as florações de cianobactérias e afeta a biota devido à alteração organoléptica da água e a liberação de toxinas. O objetivo deste estudo foi avaliar o efeito de microcistinas contidas no extrato bruto da cianobactéria Radiocystis fernandoi (cepa R28) no peixe Hoplias malabaricus quanto ao grau de comprometimento estrutural e funcional do fígado, o potencial de acumulação no músculo e possível risco para a saúde humana. Traíras foram injetadas intraperitonealmente com 100 μg MC-LReq kg-1 seguindo 2 protocolos experimentais: (i) exposição aguda com a aplicação de uma única dose do extrato bruto e avaliação após 12 e 96h e (II) exposição crônica com dose injetada a cada 72h durante 30 dias. Biomarcadores genotóxicos, bioquímicos, fisiológicos e morfológicos foram utilizados para avaliar a ação das toxinas, danos estruturais e ultraestruturais, mecanismos de desintoxicação no fígado e alterações no metabolismo energético. A cepa R28 produziu majoritariamente as variantes MCRR e MC-YR evidenciando potencial hepatotóxico. A MC-YR acumulou no fígado após exposição aguda e crônica e a MC-RR apenas após exposição crônica. Não ocorreu acúmulo de MC no músculo. O potencial de acumulação das variantes (MC-RR e MC-YR) depende da sua concentração, sistema de defesa do organismo para sua depuração e da biomagnificação. A exposição aguda e crônica causou inibição da atividade da proteína fosfatase de serina/treonina do tipo PP2A, aumento da atividade da alanina e aspartato aminotransferases e bilirrubina direta no plasma evidenciando danos hepáticos. Macroscopicamente ocorreu alteração da massa, cor e textura do fígado; microscopicamente a morfologia dos hepatócitos e as organelas intracelulares foram alteradas e ocorreu dilatação dos sinusóides e hiperemia. Após 30 dias, a frequência de alterações aumentou e o fígado apresentou tecido fibroso descaracterizando a arquitetura do parênquima hepático. As alterações no metabolismo intermediário como glicose, glicogênio hepático, piruvato e lactato em fígado, músculo e plasma evidenciaram aumento da demanda energética e estresse fisiológico. Além disso, ocorreu ativação do sistema de biotransformação de fase I e alterações no sistema antioxidante celular. Sinais de recuperação morfofuncional do fígado foram observados após 96 horas de exposição (dose única) a MC, mas não após 30 dias e não houve sinais de regeneração celular. Danos no DNA também foram observados em células hepáticas. As alterações bioquímicas e estrutura do fígado evidenciaram comprometimento funcional do órgão. Em conclusão, as microcistinas presentes no extrato bruto da cianobactéria R. fernandoi (cepa R28) associadas a outras substâncias presentes no extrato podem comprometer a saúde e sobrevicência do animal.

The liver presented exceptional characteristics, like controlling energy production, immunological defenses, and blood reserve. In the environment like in the work place, the human is exposed to a different kind of hepatotoxic compounds, for example, on inks and derivatives (2-nitropropane), chemical reagents (carbon tetrachloride) and in tobacco smoke (2-nitropropane and cadmium). In fact, is interesting studies of therapies which protect or ameliorated the damage induced by these compounds. Considering the growing interesting around organochalcogens, in special interest, diphenyl diselenide (PhSe)2, which posses important pharmacological properties, such as: anti-ulcer, antiinflammatory, antinociceptive, anti-hyperglycemic, protected against orofacial diskinesia induced by reserpine and halopheridol and may act on memory facilitation in mice, the hepatoprotective properties of this compound induced by different models of liver damage (2-nitropropane, cadmium and carbon tetrachloride) were examined. The results demonstrated that (PhSe)2 (100 µmol/kg) significantly reduced hepatic markers levels when compared to 2-nitropropane (2-NP) group. Treatment with diphenyl diselenide, at all doses, effectively protects against the increase of lipid peroxidation when compared to 2-NP group. In addition, histological examination revealed that 2-NP treatment causes a moderate swelling and degenerative alterations on hepatocytes and (PhSe)2 protects against these alterations. This study evidences the protective effect of diphenyl diselenide by 2-NP-induced acute hepatic damage. In addition the effect of post-treatment with (PhSe)2 on liver damage induced by 2-NP was also examined. (PhSe)2 effectively restored the increase of aminotransferase activities and urea level when compared to the 2-NP group. At the highest dose (100 mol/kg), (PhSe)2 decreased -glutamyl transferase activity (GGT) and ameliorated the increase of hepatic and renal lipid peroxidation when compared to 2-NP group. 2-NP reduced catalase activity (CAT) and did not alter superoxide dismutase activity (SOD) nor ascorbic acid level. This study points out the involvement of CAT activity in 2-NP-induced acute liver damage and suggests that the post-treatment with diphenyl diselenide was effective in restoring the hepatic damage induced by 2-NP. Similar results were obtained with cadmium (Cd), an environmental toxic metal implicated in human diseases. Cadmium content determined in the tissue of rats exposed to cadmium chloride (CdCl2) provides evidence that the liver is the major cadmium target. The concentration of cadmium in liver was about three fold higher than that in kidney, and (PhSe)2 reduced about six fold the levels of this metal in liver of rats exposed. Rats exposed to CdCl2 showed histological alterations abolished by (PhSe)2 administration. In addition, (PhSe)2 administration ameliorated plasma malondialdehyde (MDA) levels, aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), lactate dehydrogenase (LDH) and GGT activities increased by CdCl2 exposure. In conclusion, this study demonstrated that co-treatment with (PhSe)2 ameliorated hepatotoxicity and cellular damage in rat liver after sub-chronic exposure with CdCl2. The proposed mechanisms by which (PhSe)2 acts in this experimental protocol are its antioxidant properties and its capacity to form a complex with Cd. On the contrary, the administration of (PhSe)2 potentiated acute hepatic damage induced by carbon tetrachloride (CCl4), as manifested by an increase in biochemical parameters (AST, ALT, ALP, GGT and BT) and severe alteration in histopathology. This study also demonstrated a potentiation of lipid peroxidation levels and a consequent depletion of important antioxidant defenses including catalase and ascorbic acid, suggesting that the oxidative damage is related to the potentiation effect induced by (PhSe)2. Considering the results obtained, could be suggested that (PhSe)2 present a hepatoprotective effect depending of experimental protocol. / O fígado apresenta extraordinária pluralidade funcional, destacando-se no controle de produção de energia, defesa imunológica e reserva volêmica. No meio ambiente e ocupacionalmente, o ser humano está exposto a uma variedade de compostos hepatotóxicos, como por exemplo, no uso de tintas e seus derivados (2-nitropropano), reagentes químicos (tetracloreto de carbono) e na exposição ao cigarro (cádmio e 2-nitropropano). Portanto, é interessante o estudo de terapias que previnam ou até mesmo revertam à intoxicação causada por estes compostos. Considerando o crescente interesse por compostos orgânicos de selênio, em especial o disseleneto de difenila ((PhSe)2) que possui propriedades farmacológicas mais amplas como: efeitos anti-úlcera, antiinflamatório e antinociceptivo, anti- hiperglicemiante, protege contra a discinesia orofacial induzida por reserpina e haloperidol e pode atuar na facilitação da formação de memória em camundongos. Deste modo, os efeitos hepatoprotetores deste composto frente a diferentes modelos de dano hepático (2-nitropropano, cádmio e tetracloreto de carbono) foram examinados. Os resultados obtidos neste estudo demonstraram que a administração de (PhSe)2 (100 µmol/kg) reduziu os níveis de marcadores hepáticos e os níveis de peroxidação lipídica quando comparado ao grupo tratado com 2-nitropropano (2-NP). Além disso, os exames histológicos revelaram que o tratamento com 2-NP causou alterações degenerativas nos hepatócitos e que o (PhSe)2 foi capaz de proteger, evidenciando o efeito hepatoprotetor desse composto sobre o dano hepático induzido por 2-NP. O efeito do pós-tratamento com (PhSe)2 sobre o dano hepático induzido com 2-NP também foi investigado. Este composto restaurou a atividade plasmática das enzimas aminotransferases e os níveis de uréia quando comparado ao grupo tratado com 2-NP. Na maior dose (100 mol/kg), o (PhSe)2 causou uma diminuição na atividade da enzima -glutamil transferase (GGT) e restituiu o aumento nos níveis de peroxidação lipídica hepáticos e renais quando comparado ao grupo tratado com 2-NP. O tratamento com 2-NP reduziu a atividade hepática da catalase, entretanto não alterou a atividade da superóxido dismutase (SOD) e os níveis de ácido ascórbico, sugerindo que a inibição da CAT pode estar relacionada com o aumento nos níveis de peroxidação lipídica hepática nos ratos tratados com 2-NP. Resultados similares foram encontrados quando o dano hepático foi induzido por cádmio (Cd), um contaminante ambiental implicado em várias doenças. O conteúdo de Cd determinado nos ratos expostos ao cloreto de cádmio (CdCl2) provêm evidências de que o fígado é o maior alvo da toxicidade deste metal. A concentração de cádmio no fígado foi em torno de 3 vezes maiores que os níveis encontrados no rim. O (PhSe)2 reduziu em torno de 6 vezes os níveis deste metal no fígado dos ratos expostos ao CdCl2. Além disso, a administração de (PhSe)2 causou uma redução nos níveis de malondialdeído plasmáticos (MDA), na atividade das aminotransferases, na fosfatase alcalina (ALP), lactato desidrogenase (LDH) e GGT quando comparado ao grupo tratado com cádmio. Em conclusão, esse estudo demonstrou que o tratamento concomitante com (PhSe)2 reduziu a hepatotoxicidade e o dano celular em fígado de ratos expostos ao cádmio. O mecanismo proposto para ação do (PhSe)2 pode ser devido as suas propriedades antioxidantes ou pela sua capacidade de formar um complexo com Cd. Em contraste, a administração de (PhSe)2 potencializou o dano induzido por tetracloreto de carbono (CCl4), o que foi demonstrado pelo aumento dos níveis de marcadores bioquímicos (AST, ALT, ALP, GGT and BT) e pela severa alteração na histologia. Esses estudos também demonstraram que a administração de (PhSe)2 potencializou os níveis de peroxidação lipídica com consequente depleção das defesas antioxidantes, como a catalase e o ácido ascórbico, sugerindo que o dano oxidativo está relacionado com este efeito. Considerando os resultados obtidos, podemos sugerir que o disseleneto de difenila apresenta um efeito hepatoprotetor dependendo do modelo experimental.

Conselho Nacional de Desenvolvimento Científico e Tecnológico / The liver presents extraordinary functional diversity, particularly in the control of energy production, immune defense and volemic reserve. The human being is exposed occupationally and in the environment to a variety of hepatotoxic compounds, such as the use of paints and their derivatives (2-nitropropane, 2-NP), chemical reagents (carbon tetrachloride, CCl4) and exposure to cigarette (2-NP). Therefore, it is interesting the study of therapies to prevent or even reverse the poisoning caused by these compounds. Considering that reactive oxygen species (ROS) have an important role in various diseases, especially in liver diseases, the use of antioxidant therapies should be considered. In this context, the heterocyclic compounds containing selenium in their structures have attracted the attention of researchers. Thus, this study investigated the antioxidant activity of 3-alkynyl selenophenes in models of oxidative damage in vitro and ex vivo in rats (Wistar, male, weighing 200-300g). A class of 3-alkynyl selenophene compounds with different substitutions was tested, with the objective to assess their antioxidant profile and their possible toxic effect in vitro. As a result, 3-alkynyl selenophenes had antioxidant activity, but this activity was dependent on the presence of terminal alkynes in the molecule or easy conversion to it. The possible toxic effect of 3-alkynyl selenophenes was evaluated through the activity of the enzyme δ-aminolevulinate dehydratase (δ-ALA-D) in vitro. The results showed that none of 3-alkynyl selenophenes inhibited the activity of this enzyme, suggesting that this class of compound did not present toxicity on this enzyme. From these results, selenophene h (compound that had the best antioxidant activity in vitro) was selected for the evaluation of its protective effect against oxidative damage induced by 2-NP and CCl4 (ex vivo). Selenophene h (25 mg/kg) protected against the increase of markers of liver damage (aspartate aminotransferase (AST) and alanine aminotransferase (ALT) activities) and oxidative stress induced by administration of 2-NP in rats. 2-NP induced microscopic changes, evaluated by histopathological inspections, that were protected by this compound. Selenophene h showed a protective effect against the increase of lipid peroxidation and inhibition of activity of δ-ALA-D in animals treated with 2-NP. Selenophene h protected against oxidative damage induced by CCl4 in rats. A single dose of CCl4 caused significant hepatotoxicity, evidenced by elevated plasma enzyme activity of AST and ALT, increased incidence of histopathological lesions, increased lipid peroxidation levels and the activity of Glutathione-S-transferase (GST), decreased levels of ascorbic acid and the activity of catalase and δ-ALA-D. In conclusion, 3-alkynyl selenophene protected from all these changes, confirming its hepatoprotective effect. Considering the results, we suggest that 3-alkynyl selenophene, an antioxidant, may be a useful therapy for the oxidative damage induced by 2-NP or CCl4 . / O fígado apresenta extraordinária pluralidade funcional, destacando-se no controle de produção de energia, defesa imunológica e reserva volêmica. No meio ambiente e ocupacionalmente, o ser humano está exposto a uma variedade de compostos hepatotóxicos, como por exemplo, no uso de tintas e seus derivados (2-nitropropano, 2- NP), reagentes químicos (tetracloreto de carbono, CCl4) e na exposição ao cigarro (2-NP). Portanto, é interessante o estudo de terapias que previnam ou até mesmo revertam a intoxicação causada por estes compostos. Considerando que as espécies reativas de oxigênio (EROs) apresentam importante papel sobre diversas patologias, em especial nas doenças hepáticas, o uso de terapias antioxidantes deve ser considerada. Neste contexto, destacam-se os compostos heterocíclicos contendo selênio em sua estrutura. Deste modo, neste estudo investigou-se a atividade antioxidante de 3-alquinil selenofenos em modelos de dano oxidativo in vitro e ex vivo em ratos (Wistar, machos, pesando entre 200 300 g). Para esse fim, testou-se uma classe de compostos 3-alquinil selenofeno, com diferentes substituições na estrutura química, com o objetivo de avaliar o perfil antioxidante e seu possível efeito tóxico in vitro em ratos. Como resultado, 3- alquinil selenofenos tiveram atividade antioxidante, porém esta atividade foi dependente da presença de um alquino terminal na molécula ou da fácil conversão da molécula a um alquino terminal. Além disso, o possível efeito tóxico dos 3-alquinil selenofenos foi avaliado através da atividade da enzima δ-aminolevulinato desidratase (δ-ALA-D) in vitro. Os resultados obtidos demonstraram que nenhum dos 3-alquinil selenofenos testados inibiu a atividade desta enzima, sugerindo que esta classe de compostos não apresentou toxicidade sobre a atividade da δ-ALA-D. A partir destes resultados, selecionou-se o selenofeno h (que obteve melhor atividade antioxidante in vitro) para a avaliação do seu efeito protetor contra o dano oxidativo induzido por 2-NP e CCl4 em ratos (ex vivo). O selenofeno h (25 mg/kg) protegeu contra o aumento dos marcadores de dano hepático (aspartato aminotranferase (AST) e alanina aminotransferase (ALT)) e de estresse oxidativo induzidos pela administração do 2-NP. O 2-NP induziu alterações microscópicas avaliadas por inspeções histopatológicas as quais foram protegidas pelo composto. O selenofeno h demonstrou efeito protetor contra o aumento da peroxidação lipídica e inibição da atividade da δ-ALA-D nos animais tratados com 2-NP. Além disso, o selenofeno h protegeu contra o dano oxidativo induzido pelo CCl4 em ratos. Uma única dose de CCl4 causou significante hepatotoxicidade, evidenciada por elevação da atividade plasmática das enzimas AST e ALT, aumento da incidência de lesões histopatológicas, aumento dos níveis de peroxidação lipídica e da atividade da enzima glutationa-S-transferase (GST), bem como diminuição dos níveis de ácido ascórbico e da atividade das enzimas catalase e δ-ALA-D. A partir dos resultados demonstrados, verificou-se que o selenofeno h protegeu contra todas estas alterações, confirmando o seu efeito hepatoprotetor. Considerando os resultados obtidos, pode-se sugerir que o selenofeno h, uma molécula com atividade antioxidante, pode ser uma útil terapia contra o dano oxidativo induzido pelos hepatotoxicantes: 2-NP e CCl4.

Tissue samples from spotted gar (Lepisosteus oculatus) and largemouth bass (Micropterus salmoides) were collected from Caddo Lake. Gar and bass livers were subjected to histological investigation and color analysis. Liver color (as abs at 400 nm) was significantly correlated with total mercury in the liver (r2 = 0.57, p = 0.02) and muscle (r2 = 0.58, p = 0.01) of gar. Evidence of liver damage as lipofuscin and discoloration was found in both species but only correlated with liver mercury concentration in spotted gar. Inorganic mercury was the predominant form in gar livers. In order to determine the role of mercury speciation in fish liver damage, a laboratory feeding study was employed. Zebrafish (Danio rerio) were fed either a control (0.12 ± 0.002 µg Hg.g-1 dry wt), inorganic mercury (5.03 ± 0.309 µg Hg.g-1 dry wt), or methylmercury (4.11 ± 0.146 µg Hg.g-1 dry wt) diet. After 78 days of feeding, total mercury was highest in the carcass of zebrafish fed methylmercury (12.49 ± 0.369 µg Hg.g-1 dry wt), intermediate in those fed inorganic mercury (1.09 ± 0.117 µg Hg.g-1 dry wt), and lowest in fish fed the control diet (0.48 ± 0.038 µg Hg.g-1 dry wt). Total mercury was highest in the viscera of methylmercury fed zebrafish (11.6 ± 1.86 µg Hg.g-1 dry wt), intermediate in those fed inorganic diets (4.3 ± 1.08 µg Hg.g-1 dry wt), and lowest in the control fish (below limit of detection). Total mercury was negatively associated with fish length and weight in methylmercury fed fish. Condition factor was not associated with total mercury and might not be the best measure of fitness for these fish. No liver pathologies were observed in zebrafish from any treatment.